 Tiziana Life Sciences PLC LON:TILSNASDAQ:TLSA announced an agreement with Takanawa Japan for a strategic business development plan to identify a clinical partner in Japan and other Asian countries. The pair are looking for a company to cooperate on further clinical development of Milciclib for treatment in advanced hepatocellular carcinoma HCC patients. 